Sassicaia Capital Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $464K | Buy |
+17,500
| New | +$464K | 0.29% | 24 |
|
|
2024
Q4 | – | Sell |
-10,000
| Closed | -$633K | – | 23 |
|
|
2024
Q3 | $633K | Sell |
10,000
-9,500
| -49% | -$601K | 1.84% | 9 |
|
|
2024
Q2 | $1.03M | Sell |
19,500
-20,800
| -52% | -$1.1M | 4.18% | 9 |
|
|
2024
Q1 | $3.3M | Sell |
40,300
-17,500
| -30% | -$1.44M | 14.02% | 2 |
|
|
2023
Q4 | $1.08M | Buy |
+57,800
| New | +$1.08M | 9.3% | 3 |
|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$167K | – | 56 |
|
|
2023
Q1 | $167K | Buy |
+10,000
| New | +$167K | 0.14% | 35 |
|